1-3 of 3
Vadim Ptushkin, MD
Close
Sort by
Journal Articles

Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials

Vladimir I. Vorobyev, MD PhD, Vera A. Zherebtsova, MD PhD, Egor I. Dubrovin, Liudmila A. Bychenkova, Lev S. Butaev, Larisa A. Muha, Yulia B. Kochkareva, Valentina L. Ivanova, Eugene A. Nikitin, MD PhD Professor, Gayane Tumyan, DMSc, MD PhD, Vadim A Doronin, MD, Oleg I. Krijanovski, MD PhD, Vadim Ptushkin, MD PhD Professor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5255.
https://doi.org/10.1182/blood-2019-126430
Published: 2019
Journal Articles

Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data

Aleksandr Kulagin, Vadim Ptushkin, MD PhD Professor, Elena Lukina, MD PhD Professor, Elena Gapchenko, MD, Oksana Markova, MD MSc, Eugene Zuev, MD, Dmitry Kudlay, MD PhD Professor
Journal: Blood
Blood (2019) 134 (Supplement_1): 3748.
https://doi.org/10.1182/blood-2019-125693
Published: 2019
Journal Articles

International, Practice-Based Recommendations for Prediction of Bleedings and Anti-Platelet/Anti-Coagulant (AP/AC) Co-Medications in CLL Patients Taking Ibrutinib

Evgeny Nikitin, MD, Jennifer Series, Aleksandr Poletaev, Mikhail Panteleev, PhD Dr.Sc, Prof., Georg Hopfinger, MD, Vadim Ptushkin, MD, Ulrich Jaeger, MD, Bernard Payrastre, PhD, Loic Ysebaert, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1711.
https://doi.org/10.1182/blood.V130.Suppl_1.1711.1711
Published: 2017